Physician profile
Carrie E Parent
NPI 1841391125
$1,527.99
in general payments reported to CMS, 2019-2025
17 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.00 · 2022: $108 · 2023: $585 · 2024: $288 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $328.46 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $271.77 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Organon LLC | $235.53 | 2023 | Nexplanon |
| Novo Nordisk INC | $208.36 | 2021-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $87.94 | 2023-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $64.52 | 2023-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $62.11 | 2024-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $57.82 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $48.36 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.44 | 2024-2025 | Jardiance |
| Alk-Abello, INC | $26.14 | 2025 | Neffy |
| Astellas Pharma US INC | $24.35 | 2024 | Veozah |
| Snap Diagnostics LLC | $17.99 | 2022 | |
| Amgen INC. | $16.66 | 2024 | Otezla, Repatha |
| Sumitomo Pharma America, INC. | $16.51 | 2024 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.04 | 2023 | Nexletol, Nexlizet, Contrave |
| Abbvie INC. | $13.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Parent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.